Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has results × Finasteride × Clear all
NCT02213107 2024-11-13

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

University of Rochester

Phase 2 Completed
43 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT00736645 2023-10-02

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Roswell Park Cancer Institute

Phase 2 Completed
55 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT01296672 2017-10-06

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
383 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT00438464 2016-03-09

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
204 enrolled 28 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡